Facebook
Twitter
Telegram
Fehler meldenNeoleukin Therapeutics Finanzdaten 2011-2024 | NLTX
Jahresabschluß Neoleukin Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
1.72 M | 37.6 M | 142 M | 682 M | 318 M | 52.7 M | 305 M | 333 M | 133 M | 92 M | - | - | - |
Anteile |
492 K | 55.2 M | 55 M | 54.1 M | 27 M | 23.5 M | 23.5 M | 18.9 M | 12.6 M | 8.67 M | - | - | - |
Kurshistorie |
3.49 | 0.68 | 2.58 | 12 | 9.7 | 2.64 | 14.5 | 17.3 | 8.89 | 9.75 | - | - | - |
Nettogewinn |
13.7 M | -55.2 M | -60.7 M | -33.3 M | -69.4 M | -31.6 M | -50.2 M | -37 M | -21.9 M | -24 M | -8.73 M | -7.71 M | - |
Umsatz |
- | - | - | - | - | 25 M | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-55.6 M | -56.5 M | -60.7 M | -33.7 M | -71 M | -32.6 M | -51.1 M | -37.6 M | - | - | - | - | - |
Zinsaufwendungen |
12 K | 2 K | 19 K | -44 K | 1 K | 4 K | 4 K | 1 K | -520 K | 462 K | 42.9 K | 9.47 K | - |
EBITDA |
-52.3 M | -53.3 M | -59.4 M | -47.6 M | -22.9 M | -31.5 M | -50.2 M | -37.1 M | -21.7 M | -22.2 M | -9.68 M | -7.53 M | - |
Betriebsaufwand |
55.6 M | 56.5 M | 60.7 M | 41.6 M | 23.2 M | 57.6 M | 51.1 M | 37.6 M | 21.3 M | 22.4 M | - | - | - |
Allgemeine und Verwaltungsausgaben |
11.2 M | 9.01 M | 21.5 M | 17.2 M | 18.8 M | 15.8 M | 14.9 M | 9.26 M | 5.54 M | 4.3 M | 1.78 M | 1.64 M | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Neoleukin Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
11.1 M | 56.2 M | 55.4 M | 8.53 M | 11.1 M | 55.2 M | 55.1 M | 42.5 M | 55.1 M | 55 M | 54.9 M | 42.2 M | 54.1 M | 49.4 M | 49.2 M | 38 M | 26.2 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.4 M | 23.4 B | 23.4 M | 17.7 M | 17.2 M | 17.2 M | 17.2 M | 11.8 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 3.15 M | 302 K | 302 K | 302 K | 302 K | - | - | - | - | - | - | - | - |
Nettogewinn |
-4.53 M | -2.08 M | -14.2 M | - | -13.1 M | -15.7 M | -15.4 M | - | -15.4 M | -15.1 M | -15 M | - | -2.25 M | -9.75 M | -8.64 M | - | -59.1 M | -1 K | -2.21 M | - | -15 M | 2.92 M | -14.6 M | - | -11.8 M | -13.8 M | -8.32 M | - | -8.15 M | -10.9 M | -6.71 M | - | -5.04 M | -4.75 M | -6.41 M | - | -6.28 M | -5.42 M | -4.23 M | - | -3.37 M | -812 K | -1.01 M | - | - | - | - | - | - | - | - |
Umsatz |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25 M | 25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-5.57 M | -3.07 M | -15.1 M | - | -13.6 M | -15.9 M | -15.4 M | - | -15.5 M | -15.1 M | -14.9 M | - | -2.25 M | -9.77 M | -9.07 M | - | -59.5 M | -428 K | - | - | -15.2 M | 2.69 M | - | - | -12.1 M | -14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
1.04 M | 981 K | 945 K | - | 559 K | 194 K | 13 K | - | 6 K | - | - | - | - | - | - | - | -9 K | - | -1 K | - | -262 K | -118 K | -53 K | - | -7 K | -9 K | -20 K | - | -12 K | 164 K | 123 K | - | 4 K | 5 K | 6 K | - | 2 K | 2 K | 454 K | - | 1.64 K | 1.77 K | 1.83 K | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -14.8 M | - | -12.4 M | -15 M | -15 M | - | -14.5 M | -14.6 M | -14.7 M | - | -1.67 M | -9.38 M | -8.9 M | - | -59.3 M | -346 K | 41 K | - | -15.2 M | 2.69 M | - | - | -12.1 M | -14 M | - | - | - | - | - | - | - | - | - | - | - | 71.9 K | 18.2 K | - | 45.2 K | 15.6 K | 14.8 K | - | - | - | - | - | - | - | - |
Betriebsaufwand |
5.57 M | 3.07 M | 15.1 M | - | 13.6 M | 15.9 M | 15.4 M | - | 15.5 M | 15.1 M | - | - | - | 9.77 M | 9.07 M | - | 59.5 M | 428 K | 2.66 M | - | 15.2 M | 22.3 M | 14.8 M | - | 12.1 M | 14 M | 8.52 M | - | 8.28 M | 11.1 M | 6.83 M | - | 4.92 M | 4.79 M | 6.04 M | - | 6.31 M | 5.63 M | 2.62 M | - | 3.42 M | 1.62 M | 997 K | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
4.95 M | 3.49 M | 4.03 M | - | 4.14 M | 4.92 M | 4.66 M | - | 5.56 M | 5.3 M | 5.24 M | - | 3.86 M | 4.93 M | 3.57 M | - | 10.4 M | 2.42 M | 2.56 M | - | 4.48 M | 4.31 M | 4.31 M | - | 3.61 M | 3.52 M | 2.74 M | - | 2.15 M | 1.83 M | 1.95 M | - | 1.23 M | 1.17 M | 1.47 M | - | 987 K | 1.08 M | 735 K | - | 390 K | 370 K | 424 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung